연구성과로 돌아가기

2025 연구자 정보 (443 / 657)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Lee, Sung Won
(Lee, SW)
Seoul Samsung Med Ctr, Seoul, South Korea

[JCR상위 31.2] A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia SCIE 31.2 UROLOGY & NEPHROLOGY ksleemd@dsmc.or.kr;
Lee, Yongsu
(Lee, Y)
Pohang Univ Sci & Technol, Dept Elect Engn, Cheongam Ro 77, Pohang 37673, Gyeongbuk, South Korea

[JCR상위 31.2] An area and power efficient ternary serial adder using phase composite ZnO stack channel FETs SCIE 31.2 CHEMISTRY, MULTIDISCIPLINARY;MATERIALS SCIENCE, MULTIDISCIPLINARY;NANOSCIENCE & NANOTECHNOLOGY bhlee1@postech.ac.kr;
Moon, Du Geon
(Moon, D)
Korea Univ, Guro Hosp, Seoul, South Korea

[JCR상위 31.2] A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia SCIE 31.2 UROLOGY & NEPHROLOGY ksleemd@dsmc.or.kr;
Moon, Hong Sang
(Moon, HS)
Hanyang Univ, Med Ctr, Seoul, South Korea

[JCR상위 31.2] A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia SCIE 31.2 UROLOGY & NEPHROLOGY ksleemd@dsmc.or.kr;
Moon, Ki Hak
(Moon, KH)
Yeungnam Univ, Med Ctr, Gyongsan, South Korea

[JCR상위 31.2] A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia SCIE 31.2 UROLOGY & NEPHROLOGY ksleemd@dsmc.or.kr;
Park, Hongzoo
(Park, H)
Kangwon Natl Univ, Sch Med, Dept Urol, Chunchon, South Korea

[JCR상위 31.2] Skin rash in metastatic hormone sensitive prostate cancer patients treated with apalutamide: a retrospective multicenter study in Korea SCIE 31.2 UROLOGY & NEPHROLOGY skhong@snubh.org; urojy@ncc.re.kr;
Park, Jae Shin
(Park, JS)
Daegu Catholic Univ, Med Ctr, Daegu, South Korea

[JCR상위 31.2] A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia SCIE 31.2 UROLOGY & NEPHROLOGY ksleemd@dsmc.or.kr;
Park, Jong Gwan
(Park, JG)
Dongguk Univ, Med Ctr, Goyang, South Korea
Jeonbuk Natl Univ Hosp, Jeonju, South Korea


[JCR상위 31.2] A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia SCIE 31.2 UROLOGY & NEPHROLOGY ksleemd@dsmc.or.kr;
Park, Jong Wook
(Park, JW)
Korea Canc Ctr Hosp, Dept Urol, Seoul, South Korea

[JCR상위 31.2] Skin rash in metastatic hormone sensitive prostate cancer patients treated with apalutamide: a retrospective multicenter study in Korea SCIE 31.2 UROLOGY & NEPHROLOGY skhong@snubh.org; urojy@ncc.re.kr;
Park, Sung Woo
(Park, SW)
Pusan Natl Univ, Yangsan Hosp, Busan, South Korea

[JCR상위 31.2] A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia SCIE 31.2 UROLOGY & NEPHROLOGY ksleemd@dsmc.or.kr;
Park, Sungchan
(Park, S)


[JCR상위 31.2] Skin rash in metastatic hormone sensitive prostate cancer patients treated with apalutamide: a retrospective multicenter study in Korea SCIE 31.2 UROLOGY & NEPHROLOGY skhong@snubh.org; urojy@ncc.re.kr;
Ryu, Dong Soo
(Ryu, DS)
Changwon Samsung Med Ctr, Obstet & Gynecol, Chang Won, South Korea

[JCR상위 31.2] A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia SCIE 31.2 UROLOGY & NEPHROLOGY ksleemd@dsmc.or.kr;
Seo, Won Ik
(Seo, WI)
Inje Univ, Busan Paik Hosp, Coll Med, Dept Urol, Busan, South Korea

[JCR상위 31.2] Skin rash in metastatic hormone sensitive prostate cancer patients treated with apalutamide: a retrospective multicenter study in Korea SCIE 31.2 UROLOGY & NEPHROLOGY skhong@snubh.org; urojy@ncc.re.kr;
Shin, Teak Jun
(Shin, TJ)
제1저자 Keimyung Univ, Dongsan Hosp, Daegu, South Korea

[JCR상위 31.2] A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia SCIE 31.2 UROLOGY & NEPHROLOGY ksleemd@dsmc.or.kr;
Yoo, Tag Keun
(Yoo, TK)
Eulji Univ, Nowon Eulji Med Ctr, Daejeon, South Korea M-8852-2019
Yoo, Tag

[JCR상위 31.2] A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia SCIE 31.2 UROLOGY & NEPHROLOGY ksleemd@dsmc.or.kr;
페이지 이동: